GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BIOGY) » Definitions » Cyclically Adjusted PB Ratio

BioGaia AB (BioGaia AB) Cyclically Adjusted PB Ratio : 10.98 (As of Jun. 09, 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Cyclically Adjusted PB Ratio?

As of today (2024-06-09), BioGaia AB's current share price is $12.08. BioGaia AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $1.10. BioGaia AB's Cyclically Adjusted PB Ratio for today is 10.98.

The historical rank and industry rank for BioGaia AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

BIOGY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 9.04   Med: 17   Max: 24.51
Current: 10.99

During the past years, BioGaia AB's highest Cyclically Adjusted PB Ratio was 24.51. The lowest was 9.04. And the median was 17.00.

BIOGY's Cyclically Adjusted PB Ratio is ranked worse than
94.47% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs BIOGY: 10.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioGaia AB's adjusted book value per share data for the three months ended in Mar. 2024 was $2.062. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.10 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


BioGaia AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioGaia AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Cyclically Adjusted PB Ratio Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.93 20.64 14.85 9.15 9.19

BioGaia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.63 11.54 9.60 9.19 10.95

Competitive Comparison of BioGaia AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted PB Ratio falls into.



BioGaia AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioGaia AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.08/1.1
=10.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, BioGaia AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.062/132.2054*132.2054
=2.062

Current CPI (Mar. 2024) = 132.2054.

BioGaia AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.540 100.432 0.711
201409 0.531 100.161 0.701
201412 0.523 100.225 0.690
201503 0.526 99.950 0.696
201506 0.493 99.995 0.652
201509 0.516 100.228 0.681
201512 0.538 100.276 0.709
201603 0.526 100.751 0.690
201606 0.463 101.019 0.606
201609 0.500 101.138 0.654
201612 0.520 102.022 0.674
201703 0.593 102.022 0.768
201706 0.499 102.752 0.642
201709 0.602 103.279 0.771
201712 0.638 103.793 0.813
201803 0.709 103.962 0.902
201806 0.539 104.875 0.679
201809 0.578 105.679 0.723
201812 0.645 105.912 0.805
201903 0.671 105.886 0.838
201906 0.511 106.742 0.633
201909 0.541 107.214 0.667
201912 0.621 107.766 0.762
202003 0.641 106.563 0.795
202006 0.691 107.498 0.850
202009 0.752 107.635 0.924
202012 2.068 108.296 2.525
202103 2.084 108.360 2.543
202106 2.105 108.928 2.555
202109 2.107 110.338 2.525
202112 2.045 112.486 2.404
202203 2.026 114.825 2.333
202206 1.724 118.384 1.925
202209 1.678 122.296 1.814
202212 1.882 126.365 1.969
202303 1.973 127.042 2.053
202306 1.732 129.407 1.769
202309 1.774 130.224 1.801
202312 1.960 131.912 1.964
202403 2.062 132.205 2.062

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioGaia AB  (OTCPK:BIOGY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioGaia AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (BioGaia AB) Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.